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status prediction of the three classifiers are shown 
in Table 1 
 
 
 
 
Conclusion 
It is possible to classify HPV status for HNSCC patients 
using CT image-derived features, which could lead 
to better precision treatment decision. However, the 
results should be further validated on larger and external 
datasets.  
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Purpose or Objective 
The Nordic countries are characterized by a uniform and 
public health care system for all patients. In principle all 
head and neck cancer patients are treated according to 
national guidelines in this area with a population of 26M. 
Laryngeal cancer is characterized by a difference in 
incidence rate (due to different smoking habits in these 
countries) and by the variation in the use of radiotherapy 
or surgery as the primary treatment. The Scandinavian 
Society for Head and Neck Oncology performed a survey 
of laryngeal squamous cell carcinoma (LSCC) in the Nordic 
countries with the aim to study the population-based 
epidemiology and management of LSCC. 
 Material and Methods 
 All patients identified in the Nordic cancer registries who 
were diagnosed with LSCC (ICD 32) and treated during the 
years 2011 and 2012 within these countries were included. 
All patients were followed for at least 5 years or until 
death. 
Results 
 A total of 1265 patients were identified with 185 from 
Finland (population 5,5M); Sweden 371 (9.7M); Denmark 
467 (5.6M); Norway 233 (5.1M) and Iceland 9 (0.3M). The 
localization of the tumors was as follows: glottic 66%; 
supraglottic 29%; and subglottic or not identifiable 5%. The 
proportion of glottic LSCC ranged between 61-70% with 
Denmark having the largest proportion (x%) of non-glottic 
LSCC patients. Most of the tumors were of early T class (T1 
or T2; 72%) and the proportion of these tumors ranged 
from 62% to 75% with Finland having the lowest proportion 
(x%). Nodal disease was rare in patients with glottic 
tumors but was observed in half of those with non-glottic 
cancers. Distant metastases were found in less than 5% of 
the patients. Treatment with curative intent was 
administered to 93-95% of the patients. In Denmark almost 
all patients received accelerated radiotherapy with 
chemoradiotherapy and hypoxic modification with 
nimorazole for advanced cases, and primary surgery being 
reserved only for T1a glottic cancer in a clinical trial. In 
Finland and Sweden surgery was used as a primary 
treatment modality more widely, especially in locally 
advanced (T3-4) LSCC. The 5-year overall survival (OS) for 
glottic LSCC patients ranged between 63% and 68% and for 
non-glottic LSCC patients between 39% and 44%. The 
respective 5-year disease-specific survival (DSS) figures 
for glottic and non-glottic LSCC were available for 
Denmark (83% and 68%) and Finland (88% and 55%). The OS 
was typically 20% inferior to DSS mainly due to a high level 
of (smoking-related) comorbidity. 
Conclusion 
This comprehensive population-based analysis 
demonstrates, that despite the differences in treatment 
approaches between the national protocols in the Nordic 
countries, treatment outcomes for LSCC are rather 
similar. More importantly, it remains evident that a better 
primary treatment approach is needed for the advanced-
stage disease. The overall mortality was strongly 
influenced by smoking-related comorbidity. 
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